BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

329 related articles for article (PubMed ID: 17600087)

  • 1. Let-7 expression defines two differentiation stages of cancer.
    Shell S; Park SM; Radjabi AR; Schickel R; Kistner EO; Jewell DA; Feig C; Lengyel E; Peter ME
    Proc Natl Acad Sci U S A; 2007 Jul; 104(27):11400-5. PubMed ID: 17600087
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Let-7 prevents early cancer progression by suppressing expression of the embryonic gene HMGA2.
    Park SM; Shell S; Radjabi AR; Schickel R; Feig C; Boyerinas B; Dinulescu DM; Lengyel E; Peter ME
    Cell Cycle; 2007 Nov; 6(21):2585-90. PubMed ID: 17957144
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Construction of let-7d expression vector and its inhibitory effect on HMGA2 and ras expression in human ovarian cancer cells in vitro].
    Ye H; Chen J; Huang X; Guo A; Hao P
    Nan Fang Yi Ke Da Xue Xue Bao; 2012 Dec; 32(12):1752-7. PubMed ID: 23268403
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regulation of HMGA2 and KRAS genes in epithelial ovarian cancer by miRNA hsa-let-7d-3p.
    Gunel T; Dogan B; Gumusoglu E; Hosseini MK; Topuz S; Aydinli K
    J Cancer Res Ther; 2019; 15(6):1321-1327. PubMed ID: 31898667
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Overexpression of high mobility group A2 and its correlation with microRNA let-7 family in serous ovarian cancers].
    Yang J; Zhang Q; Dong JQ; Chang XH; He XJ
    Beijing Da Xue Xue Bao Yi Xue Ban; 2012 Oct; 44(5):749-54. PubMed ID: 23073586
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Disrupting the pairing between let-7 and Hmga2 enhances oncogenic transformation.
    Mayr C; Hemann MT; Bartel DP
    Science; 2007 Mar; 315(5818):1576-9. PubMed ID: 17322030
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Correlation of overexpression of HMGA1 and HMGA2 with poor tumor differentiation, invasion, and proliferation associated with let-7 down-regulation in retinoblastomas.
    Mu G; Liu H; Zhou F; Xu X; Jiang H; Wang Y; Qu Y
    Hum Pathol; 2010 Apr; 41(4):493-502. PubMed ID: 20004941
    [TBL] [Abstract][Full Text] [Related]  

  • 8. miR-145, targeting high-mobility group A2, is a powerful predictor of patient outcome in ovarian carcinoma.
    Kim TH; Song JY; Park H; Jeong JY; Kwon AY; Heo JH; Kang H; Kim G; An HJ
    Cancer Lett; 2015 Jan; 356(2 Pt B):937-45. PubMed ID: 25444913
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Do cells let-7 determine stemness?
    Dröge P; Davey CA
    Cell Stem Cell; 2008 Jan; 2(1):8-9. PubMed ID: 18371414
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genomic imbalances are involved in miR-30c and let-7a deregulation in ovarian tumors: implications for HMGA2 expression.
    Agostini A; Brunetti M; Davidson B; Tropé CG; Heim S; Panagopoulos I; Micci F
    Oncotarget; 2017 Mar; 8(13):21554-21560. PubMed ID: 28423547
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular events in endometrial carcinosarcomas and the role of high mobility group AT-hook 2 in endometrial carcinogenesis.
    Romero-Pérez L; Castilla MÁ; López-García MÁ; Díaz-Martín J; Biscuola M; Ramiro-Fuentes S; Oliva E; Matias-Guiu X; Prat J; Cano A; Moreno-Bueno G; Palacios J
    Hum Pathol; 2013 Feb; 44(2):244-54. PubMed ID: 22974476
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MiR-204 regulates HMGA2 expression and inhibits cell proliferation in human thyroid cancer.
    Wu ZY; Wang SM; Chen ZH; Huv SX; Huang K; Huang BJ; Du JL; Huang CM; Peng L; Jian ZX; Zhao G
    Cancer Biomark; 2015; 15(5):535-42. PubMed ID: 26406941
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical significance of high mobility group A2 in human gastric cancer and its relationship to let-7 microRNA family.
    Motoyama K; Inoue H; Nakamura Y; Uetake H; Sugihara K; Mori M
    Clin Cancer Res; 2008 Apr; 14(8):2334-40. PubMed ID: 18413822
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hypermethylation of let-7a-3 in epithelial ovarian cancer is associated with low insulin-like growth factor-II expression and favorable prognosis.
    Lu L; Katsaros D; de la Longrais IA; Sochirca O; Yu H
    Cancer Res; 2007 Nov; 67(21):10117-22. PubMed ID: 17974952
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antiproliferative effects by Let-7 repression of high-mobility group A2 in uterine leiomyoma.
    Peng Y; Laser J; Shi G; Mittal K; Melamed J; Lee P; Wei JJ
    Mol Cancer Res; 2008 Apr; 6(4):663-73. PubMed ID: 18403645
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nuclear Localization Signal-Enhanced Polyurethane-Short Branch Polyethylenimine-Mediated Delivery of Let-7a Inhibited Cancer Stem-Like Properties by Targeting the 3'-UTR of HMGA2 in Anaplastic Astrocytoma.
    Yang MY; Chen MT; Huang PI; Wang CY; Chang YC; Yang YP; Lo WL; Sung WH; Liao YW; Lee YY; Chang YL; Tseng LM; Chen YW; Ma HI
    Cell Transplant; 2015; 24(8):1431-50. PubMed ID: 24898358
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High-mobility-group A2 overexpression provokes a poor prognosis of gastric cancer through the epithelial-mesenchymal transition.
    Lee J; Ha S; Jung CK; Lee HH
    Int J Oncol; 2015; 46(6):2431-8. PubMed ID: 25845850
    [TBL] [Abstract][Full Text] [Related]  

  • 18. miR‑485‑5p inhibits bladder cancer metastasis by targeting HMGA2.
    Chen Z; Li Q; Wang S; Zhang J
    Int J Mol Med; 2015 Oct; 36(4):1136-42. PubMed ID: 26239806
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of microRNAs in drug-resistant ovarian cancer cells.
    Sorrentino A; Liu CG; Addario A; Peschle C; Scambia G; Ferlini C
    Gynecol Oncol; 2008 Dec; 111(3):478-86. PubMed ID: 18823650
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Systematic gene regulation involving miRNAs during neuronal differentiation of mouse P19 embryonic carcinoma cell.
    Eda A; Tamura Y; Yoshida M; Hohjoh H
    Biochem Biophys Res Commun; 2009 Oct; 388(4):648-53. PubMed ID: 19679099
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.